Telesimulation and Behavioral Health
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03661372 |
|
Recruitment Status : Unknown
Verified October 2019 by Pacific Northwest University of Health Sciences.
Recruitment status was: Active, not recruiting
First Posted : September 7, 2018
Last Update Posted : September 16, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Self Efficacy | Other: Robot Other: Face-to-face | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 100 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Randomized |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Telesimulation and Behavioral Health: Assessment of the Integration of the Abbreviated Checklist Contextual Interview Observation Form-Adult (CIOF-A) as a Learning Tool in Interprofessional Practice & Education: A Pilot Study |
| Actual Study Start Date : | November 30, 2017 |
| Actual Primary Completion Date : | June 30, 2019 |
| Estimated Study Completion Date : | January 1, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Face-to-Face
Face-to-Face Group: At the beginning of the session self-efficacy will be measured. This group will receive an instructor-led 45 minute long lecture on how to evaluate work, love, and play behavioral health form on a standardized patient. A face-to- face standardized patient scenario will test the participant on the application of work, love, and play assessment. In this scenario, the participant will meet a standardized patient in the exam room to discuss a behavioral health concern. At the end of each session (approximately 2 hours later), self-efficacy will be measured.
|
Other: Face-to-face
Use of face-to-face patient interview using contextual interview format. |
|
Active Comparator: Robot
Robot Group: At the beginning of the session self-efficacy will be measured. This group will receive an instructor-led 45 minute long lecture on how to evaluate work, love, and play behavioral health form on a standardized patient. A robot (telesimulated) standardized patient scenario will test the participant on the application of work, love, and play assessment. In this scenario, the participant will meet a standardized patient in the exam room via a robot to discuss a behavioral health concern. At the end of each session (approximately 2 hours later), self-efficacy will be measured.
|
Other: Robot
Use of a telesimulation robot using contextual interview format. |
- Changes in Self-Efficacy in Patient Centeredness Questionnaire (SEPCQ27) 27-item [ Time Frame: Baseline and approximately 2-hours after baseline ]The SEPCQ is designed to measure confidence levels at delivering patient-centered care (A 7-point Likert scale was used with "0" (to a very low degree) and "6" (To a very high degree)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 33 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Any enrolled student at a participating program in the Yakima Valley Interprofessional Collaborative
- Age 18-33 (focusing on the Millennial Generation)
Exclusion Criteria:
- Able to read, write, and speak English due to the pilot nature of the study
- Have no pending litigation with any education entity within the YVIPEC
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03661372
| United States, Washington | |
| Pacific Northwest University of Health Sciences | |
| Yakima, Washington, United States, 98901 | |
| Principal Investigator: | Lisa Munoz, MPH | Pacific Northwest University of Health Sciences |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Pacific Northwest University of Health Sciences |
| ClinicalTrials.gov Identifier: | NCT03661372 |
| Other Study ID Numbers: |
2017-020 |
| First Posted: | September 7, 2018 Key Record Dates |
| Last Update Posted: | September 16, 2020 |
| Last Verified: | October 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

